Clincosm LogoSign in Get a demo

advanced triple negative breast cancer

Showing 1 - 5 of 5
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Triple Negative Breast Cancer Trial in Shantou (SZ011 CAR-NK)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • SZ011 CAR-NK
  • Shantou, China
    Shantou
Jan 9, 2023

Advanced Triple Negative Breast Cancer Trial in Newport Beach (N-803, PD-L1 t-haNK, Sacituzumab Govitecan-Hziy)

Active, not recruiting
  • Advanced Triple Negative Breast Cancer
  • N-803
  • +3 more
  • Newport Beach, California
    Hoag Memorial Hospital
Mar 29, 2022

Advanced Triple Negative Breast Cancer Trial in Fuzhou (Apatinib Mesylate, Albumin-Bound Paclitaxel)

Not yet recruiting
  • Advanced Triple Negative Breast Cancer
  • Apatinib Mesylate
  • Albumin-Bound Paclitaxel
  • Fuzhou, Fujian, China
    Fujian Cancer Hospital
Aug 18, 2021

Solid Tumors, Advanced Triple Negative Breast Cancer, Advanced Hormone Receptor Positive/Endocrine Refractory Breast Cancer

Terminated
  • Solid Tumors
  • +4 more
  • Lafayette, Indiana
  • +3 more
Oct 23, 2020

Non Small Cell Lung Cancer, Advanced Triple Negative Breast Cancer, Small Cell Lung Cancer Trial (Pembrolizumab, CDX-1401,

Withdrawn
  • Non Small Cell Lung Cancer
  • +5 more
  • (no location specified)
Dec 5, 2016